Navigation Links
MDS Inc. Issues Annual Filings
Date:1/29/2008

All Financial Statements for 2007 Now Available in US GAAP

TORONTO, Jan. 29 /PRNewswire-FirstCall/ - MDS Inc. (TSX: MDS; NYSE: MDZ), a leading provider of products and services to the global life sciences markets, today announced that it has issued its annual filings for the first time under US GAAP. These filings include the Annual Report, Annual Information Form, Management Proxy Circular, 40-F, and the Canadian Supplement to the annual MD&A.

To assist investors with understanding the impact of the conversion from Canadian to US GAAP, both an "MDS US GAAP Primer", which provides an overview of the relevant differences between US and Canadian GAAP affecting MDS, and reconciliation tables for MDS and its business units are being made available on the MDS website.

MDS also published its interactive annual report today available at http://www.mdsinc.com.

About MDS Inc.

MDS Inc. is a global life sciences company that provides market-leading products and services that our customers need for the development of drugs and the diagnosis and treatment of disease. We are a leading global provider of pharmaceutical contract research, medical isotopes for molecular imaging, radiotherapeutics, and analytical instruments. MDS has more than 5,500 highly skilled people in 29 countries. Find out more at http://www.mdsinc.com or by calling 1-888-MDS-7222, 24 hours a day.


'/>"/>
SOURCE MDS Inc.
Copyright©2008 PR Newswire.
All rights reserved

1

GOOD

Page: 1

Related medicine news :

1. MDS Issues MDS US GAAP Primer
2. Health and Financial Security Issues May Be Key to New York Primary, Says AARP Poll
3. China Nepstar Chain Drugstore Launches Charitable Initiative to Promote Awareness of Low-income Working Womens Health Issues
4. PPD Updates 2007 Forecast; Issues Financial Guidance for 2008
5. Childrens Hospital physicians publish review of transplant issues in patients with biliary atresia
6. Beacon Research Issues TraderNotes on CERP, SEED, OSIR, GFRE, RIMM
7. ADA Issues New Clinical Practice Recommendations
8. Treating oft ignored non-cancer health issues after cancer diagnosis prolongs survival
9. got breakfast?(TM) Foundation Issues Statement on Recently Released Florida State Plan of Action from the Governors Council on Physical Fitness
10. HealthSouth Issues Statement on Medicare Bill and 75% Rule
11. American Cancer Society President Elmer Huerta Shares Inspirational Message on Azteca Americas Issues: Caras Y Voces

Post Your Comments:
*Name:
*Comment:
*Email:
(Date:11/25/2009)...zlesmile,llc www.dazzlesmile.com andOptimalHealthS...67-pagefederallawsuitagainstEpicAdvertisingAKAAzoo...esLimited,andAtLastFulfillment.The13-countComplain...ictofUtah,allegesmassivenationalconsumerfraud,coun...oducts,violationsoftheRacketeeringInfluencedandCor...
(Date:11/25/2009)...roveOverallOutcomesforLungCancer ,, WASHINGTO...rAlliance-California(LCA-CA)issuedits2ndAnnual Rep...ntofprogressbeingmadeagainstthislethaldiseaseinthe...ance(LCA),theonlynationalorganizationdedicatedexcl...ithoratriskforlungcancer. ,, (Photo: http://www...
(Date:11/25/2009)...matology (ASH) is pleased to recognize the followi...bstracts in the categories of undergraduate studen...ysician, and post-doctoral,fellow. Merit Award wi...g,travel reimbursement. , The 2009 Merit Award ...imberly Fan , Donor Dendritic Cells Home to Lymph...
(Date:11/25/2009)... , An innovative treatment for HIV patients dev...ers has passed its first clinical trial with flyin...stomized for each individual patient, and was deve...e of the MUHC in collaboration with Dr. R. Skaly f...ade for the individual patient an "haute couture"...
(Date:11/25/2009)...atients with liver lesions, researchers find , ...ding the drug cetuximab to neoadjuvant chemotherap...ul surgery in colorectal cancer patients with inop...ests. , , Tumors spread to other parts of the ... cancer. Most commonly, the cancer spreads to the ...
Breaking Medicine News(10 mins):Health News:dazzlesmile Sues Epic Advertising and Jesse Willms 2Health News:Lung Cancer Alliance-California Releases 2nd Annual State-Specific Report Card On Lung Cancer 2Health News:ASH announces 2009 Merit Award winners 2Health News:Tailor-made HIV/AIDS treatment closer to reality 2Health News:Cetuximab Helps Treat Colorectal Cancer 2
... Unveiled at POH Riley Foundation,s Nov. 17...rysler Jeep Superstores Will Help Foundation Break...is Year,s Gala, BIRMINGHAM, Mich., Nov. 13 Needy...atrician check-ups,with the generous donation of a...
...k for obesity often focus on improving eating habi...ty. While this is one way to address the issue, an...could simply come down to positive parenting, acco... neglect in childhood and childhood obesity. Previ...
...nucleotides encoding some of the bodies, 20 amino ...normal expansion of trinucleotide repeats is the k... disorders, including Huntington disease. , Scien...of a normal repeated DNA sequence alters gene expr...
...r pancreatic surgery, most notably bleeding, infec...n can also be seen due to internal hernias or anas...wel obstruction in this setting is intussusception...ed by Dr. Luis Leons group on the November 28 issu...
...ns to deliver a comprehensive drug ...ISCO, Nov. 13 ORACLE OPENWORLD 2007 -- Tata,Consu... a leading global IT,services, business solutions ... integrated & comprehensive Drug Safety,and Pharma...
...., Nov. 13 ,PDX- NHIN and Health Market Science of...entered into an agreement to jointly market to PDX...ile(TM), a database which currently,contains over ...0071026/NEF019LOGO ) Jeff Farris, PDX-NHIN-Rx.co...
Other Medicine News:Health News:Needy Women and Children in Oakland County Get Big Boost for Free Health Care With Donation of Two-Year Lease for Chrysler 300C 2Health News:Needy Women and Children in Oakland County Get Big Boost for Free Health Care With Donation of Two-Year Lease for Chrysler 300C 3Health News:A higher risk of obesity for children neglected by parents 2Health News:Antegrade bowel intussusception can cause recurrent, chronic postoperative intestinal obstruction 2Health News:TCS, Oracle and DrugLogic Prescribe Safety in a Capsule(TM) 2Health News:TCS, Oracle and DrugLogic Prescribe Safety in a Capsule(TM) 3Health News:TCS, Oracle and DrugLogic Prescribe Safety in a Capsule(TM) 4Health News:PDX-NHIN and Health Market Science to Jointly Market Standardized Prescriber File 2Health News:PDX-NHIN and Health Market Science to Jointly Market Standardized Prescriber File 3
(Date:11/25/2009)....25/PRNewswire-FirstCall/--Abaxis,Inc.(Nasdaq: ABA...arebloodanalysissystems,announcedtodaythatClintSev...atthe21stAnnualPiperJaffrayHealthCareConferenceonW...illbeheldattheNewYorkPalaceHotelinNewYorkCity. ,...andmarketsportablebloodanalysissystemsforuseinanyv...
(Date:11/25/2009)...wswire-FirstCall/--NuVasive,Inc.(Nasdaq: NUVA ),am...inimallydisruptivesurgicaltreatmentsforthespine,an...November30,2009,at5:30p.m.ET/2:30p.m.PT.Theconfere...mentfortheCompany,sproductsandwillincludecommentsf...ion.Thedial-innumbersare1-877-407-4018fordomesticc...
(Date:11/25/2009)...swire/--Reportlinker.comannouncesthatanewmarketres...nasalDrugDelivery-USMarketTrends&Analysis htt...Delivery---US-Market-Trends--Analysis.html ,, ...ansionoftherapeuticapplicationsfromthedeliveryofco...emictherapeuticdrugs.Thefutureofthetechnologyhinge...
Breaking Medicine Technology:NuVasive Announces Conference Call and Webcast Regarding Reimbursement 2NuVasive Announces Conference Call and Webcast Regarding Reimbursement 3Reportlinker Adds Intranasal Drug Delivery - US Market Trends & Analysis 2Reportlinker Adds Intranasal Drug Delivery - US Market Trends & Analysis 3Reportlinker Adds Intranasal Drug Delivery - US Market Trends & Analysis 4Reportlinker Adds Intranasal Drug Delivery - US Market Trends & Analysis 5Sentry Data Systems Announces Claims Guardian 28TM 29 50150 1Sentry Data Systems Announces Claims Guardian 28TM 29 50150 2Sentry Data Systems Announces Claims Guardian 28TM 29 50150 3Clavis Pharma Raises NOK 129 Million 28USD 20 Million 29 in a Private Placement to Fund Further Development of its Pipeline of Novel Anticancer Drug 12798 1Clavis Pharma Raises NOK 129 Million 28USD 20 Million 29 in a Private Placement to Fund Further Development of its Pipeline of Novel Anticancer Drug 12798 2Clavis Pharma Raises NOK 129 Million 28USD 20 Million 29 in a Private Placement to Fund Further Development of its Pipeline of Novel Anticancer Drug 12798 3Clavis Pharma Raises NOK 129 Million 28USD 20 Million 29 in a Private Placement to Fund Further Development of its Pipeline of Novel Anticancer Drug 12798 4Clavis Pharma Raises NOK 129 Million 28USD 20 Million 29 in a Private Placement to Fund Further Development of its Pipeline of Novel Anticancer Drug 12798 5Brown Takes Over Reins as Chair of AOSSM Medical Publishing Board of Trustees 50148 1Brown Takes Over Reins as Chair of AOSSM Medical Publishing Board of Trustees 50148 2Brown Takes Over Reins as Chair of AOSSM Medical Publishing Board of Trustees 50148 3
...dy Comparing Leading Hepatitis C Therapies Provide...cal Practice, MILAN, Italy, April 26 Final resul..., clinical study comparing the,leading therapies f...e 43rd,Annual Meeting of the European Association ...tant insights that may help guide clinical practic...
...ts achieve undetectable HCV RNA levels following 4...egasys(R) plus Copegus(R) -, - Safety and tolerabi...ys plus Copegus - ...bsite -, - Conference call scheduled for Friday, A... and 7:00 PM CEST (Milan) -, PRINCETON, N.J. ...
Other Medicine Technology:Final Results of Ideal Study Presented at Annual Meeting of the European Association for the Study of the Liver (EASL) 2Final Results of Ideal Study Presented at Annual Meeting of the European Association for the Study of the Liver (EASL) 3Final Results of Ideal Study Presented at Annual Meeting of the European Association for the Study of the Liver (EASL) 4Final Results of Ideal Study Presented at Annual Meeting of the European Association for the Study of the Liver (EASL) 5Final Results of Ideal Study Presented at Annual Meeting of the European Association for the Study of the Liver (EASL) 6Final Results of Ideal Study Presented at Annual Meeting of the European Association for the Study of the Liver (EASL) 7Final Results of Ideal Study Presented at Annual Meeting of the European Association for the Study of the Liver (EASL) 8Final Results of Ideal Study Presented at Annual Meeting of the European Association for the Study of the Liver (EASL) 9Final Results of Ideal Study Presented at Annual Meeting of the European Association for the Study of the Liver (EASL) 10Pharmasset Presents Results of 4-Week Combination Study of R7128 for the Treatment of Chronic Hepatitis C 2Pharmasset Presents Results of 4-Week Combination Study of R7128 for the Treatment of Chronic Hepatitis C 3Pharmasset Presents Results of 4-Week Combination Study of R7128 for the Treatment of Chronic Hepatitis C 4Pharmasset Presents Results of 4-Week Combination Study of R7128 for the Treatment of Chronic Hepatitis C 5Pharmasset Presents Results of 4-Week Combination Study of R7128 for the Treatment of Chronic Hepatitis C 6
Ultra-Sensitive Testosterone EIA
...kes it possible to determine the,vitamin levels in...es all reagents in,ready to use form for preparati... the columns. ,The advantage of HPLC analytics is ...ngle test. The HPLC complete,system enables even l...
Steroid 21-Hydroxylase (21-OH) Autoantibody RIA
...st kit is intended for the quantitative determinat...eptionally sensitive ELISA procedure offers sensit...iding for accurate establishment of post-ablation ...l methods. Furthermore, with the ability to accura...
Medicine Products: